Venture Life Share Discussion Threads

[redartbmud] 06/2/2017 16:41

A post from the Ltg board.

3 years ago, Andrew Brodie was chairman and largest single shareholder of two small AIM companies, RWS and LTG.
The latter had just been reversed into a very small cash shell.
Now, the two companies have a market capitalisation in excess of £1bn, and Brodie still hasn't sold a single share-in fact, he has supported LTG's latest proposed acquisition (which if successful will it appears further increase the company's overseas and recurring earnings) by buying more.
Seems like a man (and management team) to follow to me.

A little bit of an exaggeration, the figure is c£930m but I get te drift. For now, I am hanging onto Ltg. The market seems to like the purchase, despite the hefty price.

Brodie would appear to be the man.

red

[apad] 06/2/2017 16:18

Mea maxima culpa.
T'was ever thus.
apad

[redartbmud] 06/2/2017 16:11

Spotted that. I didn't leak it did you?

red

[apad] 06/2/2017 15:28

I see the market has noticed our measured appreciation of AMS, red.
apad

[pj 1] 06/2/2017 15:26

Serial disappointer AEX actually hits more gas than expected. Things actually looking promising after decades of blowing other peoples cash.

Its Tanzania though so an outside chance it could all disappear over night!

[redartbmud] 06/2/2017 14:58

A bit of volatility on Rsw today, on thin trades.

red

[apad] 06/2/2017 14:02

WEIR is outperforming other O&G services.
I presume it is because of US shale companies needing its pumps.
apad

[apad] 06/2/2017 13:48

Seems to have a niche all to itself, j.

One of my near misses :-(

apad

[janeann] 06/2/2017 09:51

Nice update from ACSO today .....
it expects Group revenues to be in line with expectations for the year ended 31 December 2016, and expects to be ahead of expectations with respect to profitability. This strong performance has been achieved despite significant and accelerated investment in product and infrastructure to support business and growth opportunities in geographies outside its traditional core markets, together with further investment in the recently launched accesso Prism wearable device.

The Board is also pleased to report a strong start to 2017 where all accesso business lines are reporting good momentum.

[pet lover] 05/2/2017 13:07

PVG

I see HYDRUS has posted on this company.

My views put in a somewhat different fashion.


PVG sells and administers pet health plans to independent vets and groups of vets and is going flat out with its global ambitions.

PVG collects direct debit fee per pet per month plus set up fee per new pet plus practice set up fee plus manufacturer support fees.


I want to show you how shareholder value can be created:

This example is from an early adopter in the USA who is currently selling at the rate of 600 plans a year.

Take just one US Hospital/Clinic selling 600 pet plans at £25.00 each.

£15,000 a year of fast growing recurring revenue. After the tipping point has been reached (UK has done this ) across the USA portfolio of clinics margins go over 90%. £13,500 les tax =
£11,000.
Multiply by a very high PE of 40 (sales growth of 65) and just one sales outlet has put £440,000 onto the companies market cap.


10 clinics could produce £4.4M
100 clinics could produce £44M
1,000 clinics could produce £440M

Market size in the USA is 24,000 clinics and PVG has 10,000 leads from wholesalers who supply 10,000 plus clinics. The wholesalers sales jump 100% from extra sales when a pet owner signs up to a plan and his/ her pet receives the correct recommended amount of treatments throughout the year.
The reps from the wholesalers get PVG "S foot in the door,it's a two way thing.
😺😺

Finally lumps of 200,000 shares have recently been changing hands for just short of half a million pounds a time, pointing to serious positions being accumulated.

[redartbmud] 05/2/2017 11:07

L

Forgot, they have to maintain customer numbers to make the model work. To do that they have to offer keen prices.

red

[redartbmud] 05/2/2017 10:58

Lauders

SSE:
I hold it in my Sipp for income.
Just a few points:
1.They still have to invest very large sums in developing modern infrastructure, and borrow money to do so. The industry operates on a funding formula that works in their favour. Do not write off regulators changing this, in the future, to the disadvantage of the company. The debt could be the downfall.
2. Prices are a political football. Corbyn, for example, would almost be prepared to limit prices charged to the customer to below purchase cost. Utilities are already of off balance sheet extension of government.
3. The bigger companies operate at a disadvantage to the smaller boutique businesses and use PR to disguise the fact - with the covert support of politicians and direct support of the media. It is popular. True competition is a myth.
4. It is tough to manage the cost of energy, oil volatility being a major factor.
5. The carbon issue will never go away, neither will the associated costs.
6. I would be happy for SSE to build wind turbines, as long as they sell on the farms when complete. I am not convinced on the longevity/cost maintenance of the technology. Let someone else take the risk.
7. I took the view that interest rates would stay lower for longer. Indeed I bought fixed interest at or around par and continue to hold. Whilst I might have sold for a greater capital gain, I am still getting the income. I am watching this like a hawk. When it changes there could be carnage.
8. Hargreaves numbers - PE 12.4, yield 6.04% and an intention to maintain the dividend at least in-line with RPI inflation for the next couple of years. That is not too demanding, unless and until the goal posts change.
9. No growth in the share price for the last couple of years, hence 'Buy the Dips, sell the Rises' policy.

Just my thoughts. I hope that I have not left anything fundamental out of the argument. The company remains not fully in control of it's own destiny in a sector that is not truly private.

red

[apad] 05/2/2017 10:53

ps
I don't think the rule in and out issue is in the investment discourse. If it works it will be a massive change in the efficacy of the test that will massively power the share price.

[apad] 05/2/2017 10:48

"allowing for safe evaluation of clinical delta changes."
I'm hoping that this means positive and negative, so not requiring additional tests or specialist interpretation.

I agree with you about FREE, dacian. It's just such an impressive company it tempts me. Succumbing to temptation not usually being a good thing :-)

apad

[lauders] 05/2/2017 10:05

Thank you too dacian. Nice link. For those rushed for time the conclusion to A075 states "The high sensitivity cTnI in development by Siemens for the ADVIA Centaur Immunoassay Systems has a 10% Total CV at a cTnI concentration 10-fold
lower than the 99th percentile, while the 100 uL sample volume is unchanged compared
to the previous contemporary sensitive assay generation. This new assay represents an 8- to 10- fold sensitivity increase over current contemporary cTnI methods and will afford a new analytical window at low cardiac troponin I levels allowing for safe evaluation of clinical delta changes. *Under development. Not available for sale.
Product availability will vary by country. ADVIA Centaur and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc. or its affiliates.

The use of "WILL AFFORD" sounds rather positive and after 10 years of work with BVXP I somehow doubt it really will never be a reality". Can anyone really see it NOT going to plan?

[apad] 05/2/2017 08:07

You're welcome, L.

My blanket ban on insurance companies doesn't mean LGEN isn't a good investment.
It's just that I need to limit what I research and their balance sheets are difficult to understand. Same as banks.
I would make an exception for CSN if I was after income, because it is small enough to understand better. Recommended it to a mate years ago and he is well-pleased.

[lauders] 05/2/2017 07:34

Thank you APAD. I like LGEN as I think they are diversifying a bit and my recent purchase of buildings insurance was with them ;-) Just listened to the last IG conference call & OK while not the smoothest of presentations I have ever listened to by senior management. Looks like pending news from Dubai regulators could knock the price a bit lower if not what is expected?

[apad] 05/2/2017 07:12

ps
I bought IGG, RDSB &VCT on significant dips to hold for income and for recovery. I bought GSK on a less significant dip and have done some top-slicing to take gains - with hindsight I should have just put them in the sock drawer.
pps
I do not buy insurance companies or banks.

[apad] 05/2/2017 07:02

Hi L,
I bought IGG as both a recovery play and an income stock on the day of the fall.
It is now ex 9.4p divi. I think it is still a buying opportunity.
I do not plan to sell them.
They yield 6.4% for me and I expect them to survive and thrive after the regulatory threat.
I do not like SSE. Under threat of increasing debt costs and regulation. Also in and out and into wind power says it doesn't know where it's going.
However, red has a different view.
Don't know the others.
apad

[lauders] 05/2/2017 05:25

Posted a link on the BVXP board that may interest some here.

APAD - Re: IGG - Do you consider them a long term holding for income or more of a trade. I am still contemplating an investment in a higher yield company that I would more-or-less like to forget and let the income come in. Not a huge investment but enough to take care. Options now are IGG, SSE, LGEN, PHNX, BWNG.

[hydrus] 04/2/2017 20:00

I think that's right thelongandtheshortandthetall. Crazy hey.

[modform] 04/2/2017 19:19

Apad,I do agree with Paul Scott on some shares, like BOO G4M but I don't agree with him on some others like PURP, as it's business model is flawed, it needs to spend more money on marketing as it will ever make money as it has no recurring revenue. Maybe I am wrong, but that's my view atm.On Wandisco, when I researched the company, it was obvious to me that the company had something unique, their ADR and Fusion were not matched by any competitors. There was no other company offering instant access to big data with 100% uptime. Some big names like Google Amazon Oracle telecoms IBM, were all using their products. At around 90p, that was a snip.On FREE, I had a quick look long time ago, I couldn't find any uniqueness about the company. The easy of setup and its use, didn't warrant an investment case for me. It may go up much higher but not an investment case for me, and not liquid enough for trading. KWS, the best grow by acquisition company around atm.